🔎 Trials Near Me

Akèy › Maladi selil fòs › Tennessee

Etid klinik pou Maladi selil fòs nan Tennessee

22 etid pou Maladi selil fòs ap chèche patisipan nan sit nan Tennessee.

Vil nan Tennessee

Tèks ofisyèl etid la (Anglè)

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • University of Tennessee Health Science Center, Memphis
  • St. Jude Children's Res Hosp, Memphis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06612268

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 1
Laj 8 a 17 · Tout sèks · Mizajou Sep 9, 2026 · NCT07226219

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06442761

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • St. Jude Children's Research Hospital, Memphis
  • Vanderbilt University Medical Center, Nashville
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628

Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 8 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT05810181

Cooperative Assessment of Late Effects for SCD Curative Therapies

  • Vanderbilt University Medical Center, Nashville
Ap rekriteEtid obsèvasyon
Laj 4 a 65 · Tout sèks · Mizajou Jul 27, 2026 · NCT05153967

Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease

  • St Jude Children's Research Hospital, Memphis
Ap rekriteFaz 2
Jiska laj 22 · Tout sèks · Mizajou Jul 23, 2026 · NCT07616154

Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteEtid obsèvasyon
Laj 12 a 25 · Tout sèks · Mizajou Jun 29, 2026 · NCT06477289

Investigation of the Genetics of Hematologic Diseases

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 9, 2026 · NCT02720679

Sickle Cell Clinical Research and Intervention Program

  • Regional One Health, Diggs-Kraus Sickle Cell Center, Memphis
  • Methodist Adult Comprehensive Sickle Cell Center, Memphis
  • St. Jude Children's Research Hospital, Memphis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 4, 2026 · NCT02098863

Functional Ovarian Reserve in Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 10 a 18 · Fanm · Mizajou Jun 4, 2026 · NCT07392216

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • St Jude Children Hospital (NT-DMT), Memphis
  • St. Jude Children's Research Hospital (MRD-HCT), Memphis
Ap rekriteEtid obsèvasyon
Laj 3 a 20 · Tout sèks · Mizajou Jun 4, 2026 · NCT06941389

Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Ap rekrite
Laj 6 a 25 · Tout sèks · Mizajou May 18, 2026 · NCT03353584

Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 21 · Tout sèks · Mizajou May 6, 2026 · NCT05583721

Gene Editing For Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 1
Laj 18 a 24 · Tout sèks · Mizajou May 5, 2026 · NCT06506461

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 13 ak plis · Tout sèks · Mizajou May 1, 2026 · NCT04416178

School Readiness Intervention for Preschool Children With Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Ap rekrite
42 Months – 78 Months · Tout sèks · Mizajou Apr 24, 2026 · NCT06367192

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

  • Vanderbilt University, Nashville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 23, 2026 · NCT06919224

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

  • TriStar Medical Group Children's Specialists - Pediatric Oncology, Nashville
Ap rekriteFaz 3
Laj 12 a 35 · Tout sèks · Mizajou Mar 23, 2026 · NCT05477563

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • St. Jude Children's Research Hospital, Memphis
  • The Children's Hospital at TriStar Centennial, Nashville
Ap rekriteEtid obsèvasyon
Laj 14 a 37 · Tout sèks · Mizajou Jan 28, 2026 · NCT07373639

HPC Offered for PRESERVE Expansion

  • Tristar Centennial Medical Center, Nashville
Ap rekriteEtid obsèvasyon
Laj 12 a 80 · Tout sèks · Mizajou Aug 28, 2025 · NCT07145411

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • University of Tennessee at Memphis, Memphis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2025 · NCT06385886

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.